Mipomersen is an injectable medication used to reduce the levels of low-density lipoprotein cholesterol (LDL-C) in adults with homozygous familial hypercholesterolemia (HoFH). This rare genetic disorder is characterized by extremely high levels of LDL-C, or "bad" cholesterol, which increases the risk of serious heart problems. Mipomersen works by interfering with a protein involved in the production of LDL-C, thus reducing the amount of cholesterol produced by the body. The medication is given as a single weekly injection under the skin, and is usually used in combination with other cholesterol-lowering medications and lifestyle changes such as diet and exercise.
Mipomersen is a medication used to treat a specific inherited condition called familial hypercholesterolemia (FH). Here's a breakdown of how it works and what to know about it:
Purpose:
- Lowers low-density lipoprotein (LDL) cholesterol, also known as "bad" cholesterol, in adults with FH.
- FH is a genetic disorder causing abnormally high LDL cholesterol levels from birth, which significantly increases the risk of heart disease and stroke.
How it Works:
- Mipomersen is an antisense oligonucleotide drug.
- Antisense oligonucleotides are essentially short, synthetic strands of nucleic acid designed to target specific messenger RNA (mRNA) molecules.
- In FH, Mipomersen targets a specific mRNA involved in liver production of LDL cholesterol.
- By binding to this mRNA, Mipomersen reduces its activity, leading to a decrease in LDL cholesterol production.
Administration:
- Mipomersen is injected subcutaneously (under the skin) once weekly by a healthcare professional.
Important Considerations:
- Mipomersen is a complex medication with potential side effects.
- Common side effects include injection site reactions (pain, redness, swelling), flu-like symptoms (fever, chills, fatigue), and headache.
- It may also increase liver fat content and potentially cause serious liver problems in rare cases.
- Mipomersen is not for everyone and can interact with other medications.
- Pregnant or breastfeeding women should not use it.
Due to the potential risks involved, Mipomersen is typically used in patients with severe FH who haven't responded adequately to other cholesterol-lowering medications like statins.
Here are some additional points to remember:
- Mipomersen is a relatively new medication, and long-term safety data is still being gathered.
- It's crucial to talk to your doctor about the risks and benefits of Mipomersen to determine if it's the right treatment for your specific case.
- A doctor will closely monitor your cholesterol levels and liver function during treatment with Mipomersen.